Non opioid analgesics Flashcards
1
Q
ketorolac (toradol): class, use
A
- non-steroidal anti-inflammatory drug (NSAID)
- only IV NSAID in US
2
Q
ketorolac (toradol): MOA
A
- blocks cyclooxygenase (COX) 1 & 2 which reduces inflammatory response
- inhibits prostaglandin synthesis causing anti-inflammatory effects & analgesia effects
- inhibition of COX-1 also blocks synthesis of thromboxane A2 causing REVERSIBLE inhibition of platelet aggregation
3
Q
ketorolac (toradol): PK
A
- Onset: 10 min
- Peak: 2-3 hrs
- Duration: 6-8 hrs
- E1/2t: 5 hrs (prolonged by 30%-50% in elderly)
- PB: > 99%
- Metabolism: by the liver, principally by glucoronic acid conjugation
- Elimination: 60% excreted unchanged in urine
4
Q
ketorolac (toradol): SE
A
- PULM: bronchospasm in asthmatics or aspirin-sensitive patients d/t inc. leukotrienes
- GI: GI bleed, ulcerations, perforation
- GU: renal toxicity/ ARF
- HEME: prolonged bleeding time, decreased plt aggregation, anaphylaxis, Steven-Johnson Syndrome, impaired bone healing
5
Q
ketorolac (toradol): cautions/contraindications/drug interactions
A
- CAUTIONS/CONTRAINDICATIONS
- BLACK BOX: do not use in peri-op in CABG, can cause inc CV effects like MI & stroke
- pregnancy (3rd trimester, cat D - d/t premature closure of DA)
- hypersensitivity/aspirin allergy
- GI bleeding
- coag defects
- asthma
- Do not use in hypovolemic patients or patients who rely on renal prostaglandins for renal function (CHF, renal failure, hepatic cirrhosis) as this may precipitate renal failure/toxicity
- DRUG INTERACTIONS
- displaces other highly protein bound drugs
- increases levels of warfarin, phenytoin, sulfonylureas, sulfonamides, digoxin
- reduces effect of diuretics, beta blockers, ACE inhibitors via suppression of renal PGs
- increases lithium levels
- increased risk of GI bleed when combined with anti-coagulants
- probenacid increase levels of most NSAIDs - avoid ketorolac
- do not use with methotrexate - severe bone marrow supp
- displaces other highly protein bound drugs
6
Q
ketorolac (toradol): dose
A
- 30 mg IV x1 or q6hrs
- max dose: 120mg
- elderly: cut dose in 1/2 if you use at all
- do not exceed 5 days of use
7
Q
acetaminophen (tylenol): class, use
A
- class
- Non-opioid analgesic
- Antipyretic
- good choice in
- PUD
- pediatric patients
- pts who need well functioning platelets
8
Q
acetaminophen (tylenol): MOA
A
- Central anti-prostaglandin effect
- NMDA receptor blockade in CNS
- Blocks Substance P in spinal cord
- lacks peripheral effects (thus weak anti-inflammatory agent)
9
Q
acetaminophen (tylenol): PK
A
- IV peak: 15 min with max fever reduction at 30 mins
- PO peak: 30-60 min
- Rectal peak: 1-2 hrs
- Metabolism: conjugated and hydroxylated to inactive metabolites in liver
- Elimination: Little excreted unchanged by kidney
10
Q
acetaminophen (tylenol): SE
A
- renal toxicity, (but NSAIDs higher risk)
- renal papillary accumulation of metabolites can cause renal cell necrosis
- hepatic injury
11
Q
acetaminophen (tylenol): cautions/contraindications/drug interactions
A
- CAUTIONS/CONTRAINDICATIONS
- liver disease
- renal disease
- alcoholic cirrhosis (↓ dose)
- OD can cause serious hepatic injury
- Hepatotoxic metabolite N-acetyl-p-benzoquinone outnumbers glutathione
12
Q
acetaminophen (tylenol): dose
A
- 1 g IV q 6 hours
- 325 - 650 mg PO q 4-6 hours
- do not exceed 4 g/day